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Abstract Hirschsprung’s disease (HSCR) is a congenital
disorder characterised by the absence of ganglia along
variable lengths of the intestine. The RET gene is the major
HSCR gene. Reduced penetrance of RET mutations and
phenotypic variability suggest the involvement of addi-
tional modifying genes in the disease. A RET-dependent
modifier locus was mapped to 9q31 in families bearing no
coding sequence (CDS) RET mutations. Yet, the 9q31
causative locus is to be identified. To fine-map the 9q31
region, we genotyped 301 tag-SNPs spanning 7 Mb on 137
HSCR Dutch trios. This revealed two HSCR-associated
regions that were further investigated in 173 Chinese
HSCR patients and 436 controls using the genotype data
obtained from a genome-wide association study recently
conducted. Within one of the two identified regions SVEP1
SNPs were found associated with Dutch HSCR patients in
the absence of RET mutations. This ratifies the reported
linkage to the 9q31 region in HSCR families with no RET
CDS mutations. However, this finding could not be repli-
cated. In Chinese, HSCR was found associated with IKB-
KAP. In contrast, this association was stronger in patients
carrying RET CDS mutations with p = 5.10 9 10-6
[OR = 3.32 (1.99, 5.59)] after replication. The HSCR-
association found for IKBKAP in Chinese suggests popu-
lation specificity and implies that RET mutation carriers
may have an additional risk. Our finding is supported by
the role of IKBKAP in the development of the nervous
system.
Introduction
Hirschsprung’s disease (HSCR; aganglionic megacolon) is
a congenital disorder characterised by the absence of
enteric ganglia along a variable length of hindgut. There is
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significant ethnic variation in the incidence of the disease,
and it is most often found among Asians (2.8 per 10,000
live births; Amiel and Lyonnet 2001; Torfs 1998). Non-
familial HSCR has a complex pattern of inheritance and
manifests with low, sex-dependent penetrance and vari-
ability in the length of the aganglionic segment, according
to which patients are classified into short segment (S-
HSCR; 80%), long segment (L-HSCR; 15%), and total
colonic aganglionosis (TCA 5%). The male:female ratio
(M:F) is &4:1 among S-HSCR patients and &1:1 among
L-HSCR patients. HSCR presents mostly sporadically
although it can be familial (5–20% of cases), where the
recurrence risks to sibs vary from 1.5 to 33% depending on
the gender and the length of the aganglionic segment in the
proband, and the gender of the sibling (Badner et al. 1990).
The RET gene, encoding a tyrosine-kinase receptor, is
the major HSCR causing gene (Edery et al. 1994; Romeo
et al. 1994) and its expression is crucial for the develop-
ment of the enteric ganglia. Mutations in the coding
sequence (CDS) of RET account for up to 50% of the
familial cases and between 15 and 20% of the sporadic
cases indicating that additional HSCR-causing mutations
exist (Hofstra et al. 2000). Other HSCR genes identified so
far mainly code for protein members of interrelated sig-
nalling pathways involved in the development of enteric
ganglia: RET, endothelin receptor B (EDNRB), and the
transcriptional regulator SOX10. Yet, mutations in genes
other than RET (GDNF, GFRA1, NRTN, PHOX2B,
NKX2.1, SOX10, NRG1, EDNRB, EDN3, ECE-1,
KIAA1279, ZFXH1B, NTRK3, and L1CAM) account for
only 7% (Amiel et al. 2003; Angrist et al. 1996; Brooks
et al. 2005; Fernandez et al. 2009; Hofstra et al. 1996,
1999; Pingault et al. 1998; Puffenberger et al. 1994;
Wakamatsu et al. 2001). Failure to identify RET CDS
mutations in some of the RET-linked families suggests that
noncoding RET mutations, mutations in regulatory regions
of RET could also contribute significantly to the disease.
Indeed, common RET single nucleotide polymorphisms
(SNPs) are strongly associated with HSCR, with the largest
contribution to risk made by a functional SNP (rs2435357)
lying in an enhancer-like sequence in intron 1 (Burzynski
et al. 2004, 2005; Fernandez et al. 2005; Fitze et al. 2002,
2003a, b; Garcia-Barcelo et al. 2003, 2005; Sancandi et al.
2003). We have recently reported the genetic interaction of
RET intron 1 SNP (rs2435357) with HSCR-associated
NRG1 SNPs, whereby the risk to HSCR is increased by
2.3-fold for the RET risk genotype (Garcia-Barcelo et al.
2009).
Reduced penetrance of RET and other HSCR gene
mutations and variable expression of the HSCR phenotype
indicate that the disease may result from the combined
effect of several genes, whereby the outcome would be
altered RET expression (Cantrell et al. 2004; Carrasquillo
et al. 2002; Lang et al. 2000; Lang and Epstein 2003;
McCallion et al. 2003).
RET modifiers have been mapped to the following
chromosomal regions: (i) 3p21; (ii) 19q12 (Gabriel et al.
2002); (iii) 4q31.3-q32.3 (Brooks et al. 2006), and (iv)
9q31. Despite these important findings, the genes in these
loci are yet to be identified. The 9q31 locus segregated in
families of European descent harbouring no or hypomor-
phic RET mutations, yet the families still showed linkage to
10q12 (RET locus) (Bolk et al. 2000b).
To identify the HSCR locus in the 9q31 candidate
region, we have conducted dense genotyping of the region
of a Dutch patient cohort and evaluated the same region in
Chinese.
Materials and methods
The overall study was approved by the institutional review
board of The University of Hong Kong together with the
Hospital Authority (IRB: UW 07-292).
Dutch (Groningen) family-based association study
The Dutch patient cohort consisted of 140 HSCR trios that
were genotyped using Illumina GoldenGate platform for
370 SNPs spanning the 7 Mb (from 108.5 to 115.5 Mb) of
the 9q31 HSCR-associated region as described by Bolk
et al. Most of these 370 SNPs were tag SNPs. Quality
control based on identity-by-descent (IBD) revealed 3
duplicated trios. SNPs with missing genotypes ([5%) and
with minor allele frequency (MAF) \5%, and/or violating
Hardy–Weinberg equilibrium (p \ 0.001) were excluded,
leaving a total of 301 SNPs for association study. PLINK
(Purcell et al. 2007) was then used to conduct the TDT
analysis in the resulting 137 Dutch trios. As much as 16
HSCR probands carried RET CDS mutations.
Chinese case–control analysis
Subjects
For analysis of the 9q31 region in the Chinese sample, we
revised the genotype data of the candidate 9q31.3 region
obtained from a previous genome-wide association study
(GWAS) conducted on a total of 181 HSCR Chinese
patients and 386 healthy individuals (discovery group)
using Affymetrix GeneChipHuman Mapping 500K Array
as previously described (Garcia-Barcelo et al. 2009). To
that data, we included 92 additional controls recently
genotyped (see below).
For the replication of the association found when
patients were stratified according to the RET mutation
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status, we included 21 independent HSCR cases bearing
RET CDS mutations and 71 control individuals from
Mainland China (replication group).
Characteristics of the patients are depicted in supple-
mentary Tables 1 and 2.
Revision of the Affymetrix 500K data
Following the recent recommendations on quality control
standards (Sklar et al. 2008), we imposed a more strin-
gent filtering criterion based on heterozygosity to the
GWAS described above. Heterozygosity screening aims
at the identification of individuals who have more hetero-
zygous genotype calls than the average of the sample
set, since the excess of heterozygosity is likely due to
cross-contamination of samples. Hence, outliers should
be excluded from the analysis. Prior to evaluating the
heterozygosity of the samples, we pruned the SNP
dataset to avoid bias that could have been introduced by
large quantities of SNPs in strong LD. In brief, we
pruned the dataset (by removing 1 of a pair of SNPs
with r2 [ 0.25 within a window of 200 SNPs and shifts
of 50 SNPs forward at each step) using PLINK. In total,
56,000 SNPs in weak LD with each other remained. The
heterozygosity screening excluded outliers with more
heterozygous calls than the average (estimated inbreeding
coefficient lower than 3 standard deviations from the
average).
After this filtering criteria, a total of 173 HSCR cases
(31 patients bearing RET CDS mutations) and 436 controls
were included in the analysis. Restricting by the region
analysed by the Dutch group, 988 SNPs falling within the
9q31 7 Mb candidate region (from 108.5 to 115.5 Mb)
were selected. The mean call rate was 99.09%. After fil-
tering by MAF, genotyping rate and Hardy–Weinberg
equilibrium, 981 SNPs were left for analysis.
Correction for population structure and association
analysis
We used the EIGENSOFT package on the whole genome
data pruned for LD as described above to detect population
substructure. The Tracy–Widom test (implemented in
EIGENSOFT) nominated only the first two axes of varia-
tion as significant (p \ 0.05). The first axis of variation
corresponded to the ancestral differences between Northern
and Southern Chinese as seen in supplementary Fig. 1. To
correct for these ancestral differences, we applied
EIGENSTRAT (Price et al. 2006) (also implemented in
EIGENSOFT) on the candidate regions based on the two
axes of variation nominated by the Tracy–Widom test. The
Cochran-Armitage trend test was then used to assess the
levels of association of the SNPs with HSCR.
Replication stage
EIGENSTRAT could not be applied to correct the repli-
cation sample for population stratification as no genealogy
information can be inferred when only two SNPs are
genotyped. Logistic regression was carried out instead to
assess the association in the combined sample (discov-
ery ? replication samples). We included a covariate for the
sample ancestral origin (northern and southern Chinese
ancestry) and a covariate to distinguish GWAS and repli-
cation samples, thereby controlling for any possible allele
frequency differences between known populations and
between stages of association analysis. We also tested the
interaction terms between each covariate and the genotype,
which were not found to be significant (p [ 0.5 for both,
indicating that the effect is not significantly different
between subpopulations or stages). Thus, only the two
covariates were included in the final model for combined
analysis.
Results
Family-based association test on Dutch trios identifies
two associated regions on 9q31
Through TDT analysis of 301 SNPs on 137 Dutch trios, we
identified 17 SNPs (supplementary Table 3) (p \ 0.05)
showing asymmetrical transmission from parents. Of these,
10 SNPs could be grouped into 2 moderately associated
peaks of 5 SNPs each, 9q31A (110.7–111.1 Mb) and B
(112.1–112.7 Mb).
The 9q31A region encompasses a gene-rich spot which
contains 4 genes IKBKAP, C9orf6, CTNNAL1, and C9orf5
within a single LD block that spans about 100 kb. Among
the 5 associated SNPs, the strongest evidence for associa-
tion with HSCR was found for rs12351693 (p = 0.023)
and rs10979637 (p = 0.023) located within the intronic
region of CTNNAL1 (Table 1; Fig. 1a).
CTNNAL1 encodes alpha-catulin, a protein that modu-
lates the Rho signalling pathway by providing a scaffold
for the ARHGEF1 (Park et al. 2002). The expression of its
mouse homologue, Ctnnal1, was found to be severely
reduced in intestines of Ret deficient mice (Retk-/k-) when
compared to normal mice (Ret?/?) and consequently, the
gene has been considered a putative RET modifier (Heanue
and Pachnis 2006).
However, the strongest associations lied in 9q31B and
mapped upstream the TXNDC8 gene (p = 4.8 9 10-3
for rs7038415), and in the intronic region of SVEP1
(p = 2.9 9 10-3 for rs10816998) (Table 1). Other
associated SNPs within the 9q31B region, mapped to the
MUSK gene. MUSK is required for neuromuscular
Hum Genet (2010) 127:675–683 677
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junction formation in vivo and for the survival and
development of discrete neuronal subpopulations (Kiba
et al. 2009). The associations described above were
confirmed by performing 1 million permutations
(Table 1; Fig. 1).
SVEP1 is associated with HSCR in Dutch patients without
RET mutations
As it was reported that the 9q31 HSCR susceptibility locus
segregated exclusively in RET-linked families depleted of
Table 1 9q31A and B SNPs
associated with HSCR in Dutch
trios samples
A minor allele; B major allele
a p value for the transmission
disequilibrium test (TDT)
Position (bp) Allele Overlapping gene Location p valuea
A B
9q31A
rs12351693 110751336 G A CTNNAL1 Intron 13 0.023
rs10979637 110784448 C A CTNNAL1 Intron 6 0.023
rs12555920 110805558 T C CTNNAL1 Intron 1 0.041
rs1333344 110816045 A G CTNNAL1
C9orf5
Downstream
upstream
0.046
rs1044905 110821316 T C C9orf5 30 UTR 0.028
9q31B
rs7038415 112157004 A C TXNDC8
SVEP1
Upstream
Downstream
0.0048
rs10816998 112173562 G A SVEP1 Intron 46 0.0029
rs3010815 112473999 T C MUSK Intron 1 0.046
rs2766998 112571406 T C MUSK Intron 9 0.029
rs3780529 112601072 C A MUSK Intron 14 0.035
Fig. 1 Association analysis on 9q31A (110,500–111,000 kb) (left
panel) and 9q31B (112,000–112,500 kb) (right panel). a TDT
analysis on 137 Dutch HSCR trios and b Case–control study on
Chinese using 500 k. Associated SNPs listed in Tables 1 and 2 are
represented as blue diamonds. Recombination rate and genes in the
region are also shown (green ‘‘?’’ strand; red ‘‘-’’ strand)
678 Hum Genet (2010) 127:675–683
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RET CDS mutations (Bolk et al. 2000b), we stratified the
cases according to their RET CDS mutation status. We
defined RET CDS mutations as DNA changes in the coding
region or exon/intron boundaries of RET that lead to frame-
shift, non-sense or missense mutations in the RET protein
and that have not been found in at least 400 control chro-
mosomes. PolyPhen (Sunyaev et al. 2001) was used to
predict the effect of the missense mutations on the RET
protein. Truncating mutations were considered highly
deleterious.
The 301 SNPs in the 9q31 region were checked again
for association. The rs10816998 and rs7038415 SNPs
within SVEP1 were strongly associated with HSCR in
families without RET mutations. After stratification of the
patients, the OR attained a significance level of
p = 5.33 9 10-5 with OR = 2.379 (95% CI:1.542, 3.671)
for rs10816998 and p = 7.50 9 10-5 with OR = 2.345
(95% CI:1.518, 3.622) for rs7038415. These association
values survived the conservative Bonferroni correction for
multiple testing (&300 SNPs). This finding in the Dutch
population is in line with the reported linkage of 9q31 with
HSCR in patients of European descent bearing no or
hypomorphic RET mutations (Bolk et al. 2000a).
The SVEP1 SNPs, rs10816998 and rs7038415, were
then genotyped in 107 independent Dutch patients without
RET CDS mutations and 183 controls. Unfortunately, the p
value of the replication did not reach statistical
significance.
Revision of the population-based GWAS on Chinese
identifies IKBKAP as a HSCR candidate gene
We used the GWAS data (above described) to investigate
the association observed in the Dutch. After EIGEN-
STRAT correction for stratification (see Sect. Materials
and methods and supplementary material), genotypes of
981 SNPs spanning the entire 9q31 region were tested for
association on 173 HSCR patients (31 with RET CDS
mutations) and 436 controls.
In the Chinese dataset, 6 SNPs within the 9q31A region
showed association with HSCR. No association was found
in 9q31B. The loci displaying the strongest statistical evi-
dence for association were rs10979596 and rs10979597 (in
intron 25 of the IKBKAP gene) which are in complete LD
with each other (r2 = 1) (Fig. 1b; Table 2). Four additional
SNPs within IKBKAP also showed marginally significant
association (p \ 0.03) with HSCR. These include the
IKBKAP I816L missense polymorphism (rs2230793,
p = 0.024) and 3 intronic SNPs (Table 2). Mutations in
IKBKAP (inhibitor of kappa light polypeptide gene
enhancer in B cells kinase complex-associated protein,
involved in transcription elongation) are associated with a
neurodevelopmental disease, the Riley-Day syndrome, also
known as familial dysautonomia (FD) (Anderson et al.
2001; Slaugenhaupt et al. 2001). FD is an autosomal
recessive disorder that occurs almost exclusively in persons
of Ashkenazi Jewish descent. This neuropathy results from
depletion of subsets of autonomic and sensory neurons
(Slaugenhaupt and Gusella 2002). FD patients are born
with fewer neurons in their dorsal root and sympathetic
ganglia than their peers, and over time, neurons become
more scarce (Mezey et al. 2003). Most importantly, some
patients with FD also suffer from gastrointestinal dys-
function shortly after birth and interestingly, the co-
occurrence of both FD and HSCR has been reported (Azizi
et al. 1984). Interestingly, the region encompassing our 6
IKBKAP associated SNPs includes the region where FD-
causing mutations lie. Ikbkap is expressed in the rat
developing gut and IKBKAP in the human colon, sup-
porting a biological role for this gene in the development of
enteric nervous system (Bar-Shai et al. 2004; Mezey et al.
2003).
The association of IKBKAP is stronger in Chinese HSCR
patients with RET mutations
The Chinese HSCR patients were also stratified according
to the RET CDS mutation status. We then tested again the
981 SNPs in the 9q31 region for association by indepen-
dently comparing RET CDS mutation carriers (31 Chinese
HSCR patients; discovery group) against 436 controls as
well as non-carriers (142 HSCR patients) versus the same
control set.
As much as 12 SNPs were found associated with HSCR
in RET mutation carriers (p \ 0.01). Importantly, 6 of
these SNPs mapped to the IKBKAP loci in the 9q31A and
had been found associated with HSCR before the stratifi-
cation of the patients according to the mutation status
(Fig. 2). This data suggested that the initial association
detected was mainly driven by this subset of RET mutation
carriers and that the original marginal association had been
masked prior stratification because of the small number of
carriers. Among the 12 SNPs segregating with RET
mutations, 4 IKBKAP SNPs survived the conservative
Bonferroni correction for multiple testing (&1,000 SNPs)
(Table 3). The frequency of the risk SNP alleles tended to
increase with the severity of the RET mutations, yet the
small sample does not allow to draw any conclusion
(Table 3).
To validate the association of the IKBKAP SNPs with
HSCR patients carrying RET CDS mutations, we geno-
typed (by PCR followed by direct sequencing) the 2 per-
fectly linked SNPs (rs10979596 and rs10979597) in an
independent set of 21 HSCR patients (replication group)
bearing RET mutations and 71 controls collected from
mainland China. These SNPs were chosen for replication
Hum Genet (2010) 127:675–683 679
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because they fall in the same amplicon and on the basis of
genetic homogeneity between Northern and Southern
Chinese. We successfully detected the association of
rs10979596 and rs10979597 in the replication sample, with
logistic regression association value of p = 9.45 9 10-3
and OR = 3.38 (95% CI: 1.35, 8.49) (Table 4). Logistic
regression was also used for the combined analysis of
HSCR samples bearing RET mutations (discovery—31
patients and replication—21 patients). This yielded a
highly significant association of p = 2.71 9 10-6 and
OR = 3.15 (95% CI: 1.95, 5.09) for the heterozygous
genotype under an additive model. Considering the
Table 2 9q31A SNPs associated with HSCR in Chinese
Position (bp) Allele IKBKAP OR (95% CI) Frequencies p valuea
A B Cases Controls
9q31A
rs10979596 110696824 G T Intron 25 1.53 (1.10, 2.13) 0.20 0.14 0.017
rs10979597 110696853 A T Intron 25 1.53 (1.10, 2.13) 0.20 0.14 0.017
rs2230793 110699304 G T I816L exon 23 1.58 (1.20, 2.09) 0.32 0.23 0.024
rs2275630 110702228 G A Intron 19 1.68 (1.12, 2.51) 0.13 0.08 0.021
rs10979607 110707646 G A Intron 14 1.49 (1.08, 2.06) 0.20 0.14 0.025
rs4369056 110708259 T C Intron 14 1.58 (1.21, 2.08) 0.33 0.24 0.021
A minor allele, B major allele
a Corrected trend test computed using EIGENSTRAT
Fig. 2 Association analysis on RET Chinese CDS mutation carriers
(left) and Chinese non-carriers (right). Blue diamonds represent
associated SNPs before stratification by mutation status. Dark blue
diamonds indicate the 4 SNPs that survived the Bonferroni correction
multiple for testing (only 3 dark blue diamonds can be observed as
there is overlapping between two SNPs)
Table 3 IKBKAP SNPs associated (survived Bonferroni correction for multiple testing) with HSCR patients with RET CDS mutations
Risk allele MAF of risk allele OR (95% CI) Trend test p-valuec
RETa Highly deleterious Damaging Tolerating Controls
rs4369056 T 0.52 0.75 0.50 0.47 0.24 3.44 (2.04, 5.80) 1.48 9 10-5
rs2275630 G 0.25 0.38 0.30 0.19 0.08 3.83 (2.03, 7.23) 2.79 9 10-5
rs10979596b
rs10979597b
G
A
0.34 0.63 0.35 0.32 0.14 3.21 (1.83, 5.62) 3.25 9 10-5
MAF minor allele frequency; Note that the MAFs increase with the severity of the RET mutation
a Frequency in HSCR patients carrying RET CDS mutations
b Same frequencies for these two SNPs as r2 = 1
c Corrected trend test computed using EIGENSTRAT
680 Hum Genet (2010) 127:675–683
123
possible population stratification, we employed the same
logistic regression approach conditioning on the strata
defined by sample origins (Northern and Southern Chi-
nese), obtaining a significant level of association of
p = 5.75 9 10-6 with OR = 3.29 (95% CI: 1.97, 5.51)
(Table 4). Results of the latter approach were very similar,
indicating that samples collected inside and outside Hong
Kong (discovery and replication phases) were homoge-
neous, with little stratification.
Discussion
This study aims at the identification of a HSCR suscepti-
bility locus in the 9q31 region. As the association of this
region was initially reported in families of European des-
cent, we first explored the region in a Dutch cohort. As the
evaluation of an association in two populations of different
ethnic origins would definitively increase confidence in the
finding, we also explored the 9q31 region in the Chinese.
We reasoned that this strategy would allow us to determine
(i) whether the 9q31 locus exerted an effect in patients of
European descent other than those in whom the locus was
initially identified, (ii) assess whether the association of the
9q31 locus with HSCR is population specific, and if not
(iii) use population differences in LD to fine-map the gene
of interest.
Our data show an initial strong association of SVEP1
SNPs with Dutch HSCR patients bearing no RET CDS
mutations. This finding ratifies the reported linkage to the
9q31 region in HSCR families with no RET CDS muta-
tions. The case–control replication of the SVEP1 associa-
tion in the Dutch did not reach statistical significance
indicating that the initial association was spurious or that
there is a population stratification issue in the samples used
for replication. This point would need further exploration
in a much larger sample. The role of SVEP1 is not well
characterised. Study of its possible implications in the
development of the nervous system should follow.
Intriguingly, the analysis of the region in the Chinese
population demonstrated the existence of a HSCR-associ-
ated locus (IKBKAP) that, although within 9q31, is not
correlated at all with the SVEP1 locus identified in the
Dutch. The association of IKBKAP SNPs with HSCR in
Chinese became much more prominent in those patients
with RET CDS mutations which is at odds with the initial
findings described by Bolk and our own findings in the
Dutch. Importantly, the IKBKAP association with HSCR
bearing RET CDS mutations was replicated in the same
Chinese population. No IKBKAP association was detected
in the Dutch (supplementary Table 4).
We investigated whether the lack of cross-population
replication of the associations of SVEP1 and IKBKAP
SNPs with HSCR could be due to population LD and allele
frequencies differences, in which case, some true associa-
tions may not be replicated, regardless of the sample size of
the study. Close examination of the SVEP1 and IKBKAP
regions showed no major LD differences between CEU and
CHB HapMap populations indicating that lack of replica-
tion across populations was not due to differences in LD
structure (supplementary Figs. 2 and 3). Lack of replica-
tion could also be attributed to a false positive result on the
Chinese sample although we think this is unlikely since the
initial association found in Chinese was replicated in an
independent sample.
In view of these results, we would conclude that the
9q31 locus that appears associated with HSCR in families
bearing no RET CDS mutations is indeed population spe-
cific, as the findings in Chinese point to a different locus
with a completely different genetic behaviour than that
identified in the Dutch. As 9q31 locus was reported to
segregate exclusively with RET-linked families of Cauca-
sian origin whose members had weak or hypomorphic RET
CDS mutations, the investigation of SVEP1 rare variants in
these types of patients is warranted.
The association of IKBKAP in Chinese implies that RET
mutation carriers may have an additional risk. As yet, no
genotype–phenotype correlation could be found which,
Table 4 Summary of the statistics for the IKBKAP rs10979596 and rs10979597 markers in RET mutation carriers
Phase N MAF Logistica
RETb Controls RETb Controls OR (95% CI) p (adjusted) OR (95% CI) p (non-adjusted)
500K 31 436 0.34 0.14 3.31 (1.77, 6.18) 1.78 9 10-4 3.38 (1.86, 6.12) 6.13 9 10-5
Replication 21 71 0.29 0.11 NA NA 3.38 (1.35, 8.49) 9.45 9 10-3
Combined 52 507 0.319 0.13 3.32 (1.99, 5.59) 5.10 9 10-6 3.15 (1.95, 5.09) 2.71 9 10-6
NA all cases and controls used in the replication stage had the same ancestral origin of northern Chinese
a P value adjusted for population substructure in GWAS (500K) analysis and for both the substructure and strata defining analysis stages (500K
and replication) in combined analysis
b HSCR patients carrying RET CDS mutations
Hum Genet (2010) 127:675–683 681
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after all, is in line with the genetic complexity inherent to
HSCR. Had parental DNA been available, we might have
been able to provide an argument for the role of IKBKAP
SNPs on the penetrance of inherited RET CDS mutations.
SNPs may modulate the penetrance or phenotype of a
particular mutation through epistasis as exemplified by the
exclusive action of the FGFR2 and MAP3K1 SNPs in
BRCA2 mutation carriers (Antoniou et al. 2008).
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